Principles of Toxicology 3 Flashcards
define HAZARD:
is the intrinsic potential of a chemical to cause harm
- it is a qualitative expression
what is toxicity equal to ?
= f(chemistry) x f(biology) x exposure
chemistry= structure
biology- of exposed organism
the extent of exposure
define: RISK
is the probability that harm will occur under defined conditions
- often able to quantify risk and manage it
what is risk equal to ?
= hazard x exposure
what is the purpose of risk assessments ?
reduces the probability of harm which will occur in the environment
what is an example used to differentiate between hazard and risk ?
botulinus toxin
- it is one of the most potent toxins known so the hazard for it is extremely high however very few people have died from it in the UK because the exposure to it is very unlikely
therefore risk to human health is low
why does the assessment of hazard change with time ?
due to more information about the toxicology of a chemical becoming available
why does the perception of hazards change with time ?
until the advent of immunization and antibacterial chemotherapy, death from bacteria was a much greater risk to human compared to exposure to toxicants/toxins
whereas now
we have to be aware of the safety of chemicals and physical agents instead of survival
nowadays we take for granted the advances in science and technology which contribute to survival
define:RISK ASSESSMENT
the use of scientific data and a clear set of assumptions to define the likely health effects of exposure of individuals or populations to hazardous materials and situations
why is the assessment of toxicology risk difficult ?
there are many different variables to consider which contribute to the outcome
often very little information to determine these variables
what is the threshold of pathological condition ?
it is the point at which the signs and symptoms of toxicity become apparent
what is one of the major problems to determine whether chemical are safe?
major challenge to develop methods to determine their safety
when a new chemical is produced what toxicology is known ?
nothing there is complete uncertainty about nature and possible adverse effects
all that is known is that as the exposure increases the probability of toxicity will increase but the nature and incidence of adverse effects are not known
what is known about a new chemical ?
its properties are known such as hydrophobicity and acidity so therefore predictions about its toxicity can be made
what is in silico/in vitro data ?
in silico methods= predictions based on chemical structure
in vitro tests (ames test) and animal studies are often the starting points for hazard recognition
why should in silico/in vitro studies be carried out to determine toxicology ?
to determine target organ
the exposure-toxic response relationship = define the incidence and severity of adverse effects
what is the amnes test ?
used to determine whether a chemical is likely to be a mutagen or carcinogen
what is level is determined from in silico/in vitro tests ?
an estimate for the no observed adverse effect level (NOAEL)
what strategy does the estimate of NOAEL lead to ?
it leads to the RISK MINIMIZATION - this should prevent the adverse effects in man
- a means of illustrating this is by clinical trials
what is the NOAEL used to calculate ?
starting dose for phase 1 clinical trials and a dose that would be safe to take as a daily intake as a food additive
how is the NOAEL calculated ?
NOAEL for the most sensitive species and the primary toxic effect is divided by a safety factor
what is the safety factor normally and why ?
normally 100
based on the assumption that man is 10 times MORE sensitive than the most sensitive animal species and that clearance is 10x SLOWER than in animals
what does risk minimization aim to determine and also what does this mean for phase 1 clinical trials ?
aims to determine an appropraite exposure level of a chemical based on animal study data
it means that in phase 1 clinical trials there is a high degree of confidence that the chemical will not cause toxic effects
animal data is not sufficient for risk assessments so what happens next ?
need a risk assessment produced from observations in man
therefore to minimize adverse effects quantitative data needs to be obtained from man